Mucormycosis or black fungus is one of the most lethal, progressing, and rapid form of deep fungal infections in humans which is caused by group of molds called mucormycetes. It is called black fungus infection due to black nasal discharges and black patches around nose found in the initial stage. The most common variety is rhino-orbito-cerebral-maxillary, although there are also pulmonary, gastrointestinal, cutaneous, and disseminated variations. In recent years, mucormycosis has become increasingly prevalent in immunocompromised individuals, with coronavirus disease 2019 (COVID-19) infection and associated consequences as the primary source of the cause. Rhino-orbito-cerebral-maxillary variety usually involves the nose, paranasal sinuses, brain, and maxilla but the involvement of mandibular bone is exceedingly rare. In this case report, we present a case of a 59-year-old male affected with mandibular mucormycosis in post-COVID scenario which is quite rare situation.
Lymphangiomas, or lymphatic malformations (LM), are benign malformations of the lymphatic system characterized by abnormal proliferation of lymphatic vessels. It was first described by Virchow in 1854. They occur rarely in the oral cavity and involve the tongue dorsum more often. Though complete surgical excision is the gold standard and most desirable management, certain limitations restrict this approach. Laser therapy, cryotherapy, electrocautery, sclerotherapy, and intralesional injections of steroids and Bevacizumab are other treatment options in such cases. Here, we present three cases of diverse forms of lymphatic malformations treated with two different modalities of treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.